February 12, 2010

BioSyntech Announces Third Quarter Fiscal 2010 Financial Results

LAVAL, Quebec - February 12, 2010 - BioSyntech, Inc. (TSX: BSY), a biotechnology company developing biotherapeutic thermogels for regenerative medicine, today announced its financial and operational results for the third quarter of fiscal 2010, ended December 31, 2009.   More

January 07, 2010

BioSyntech Issues Common Shares as Payment of Interest

LAVAL, Quebec, January 7, 2010 — BioSyntech, Inc. (“BioSyntech” or “the Company”) (TSX: BSY), a biotechnology company developing novel products in regenerative medicine, today announced that it has exercised its option to issue 8,265,921 common shares to its holders of 2008 Debentures in payment of the $739,800.00 interest payable on December 31,   More

December 02, 2009

BioSyntech Announces Management Changes

LAVAL, Quebec – December 2, 2009 - BioSyntech, Inc. (TSX: BSY), a biotechnology company developing biotherapeutic thermogels for regenerative medicine, today announced that Ms. Antoinette Lizzi, Chief Financial Officer, will leave the Company effective December 2, 2009 and Ms. Catherine Auld, CA, will join the Company as Chief Financial Officer.   More